Arabic Arabic English English French French German German
dark

OTC Monograph Reform: OTC Sunscreen Drugs

CDER’s Office of Nonprescription Drugs (ONPD) Associate Director of Monographs, Steven Adah, PhD, discusses the deemed final order (DFO) and proposed order for over-the-counter (OTC) sunscreen drugs.

For slides and additional information: https://www.fda.gov/drugs/news-events-human-drugs/otc-monograph-reform-otc-sunscreen-drugs-12152021-12152021
——————– 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.   

Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_352
SBIA 2021 Playlist - https://youtube.com/playlist?list=PLey4Qe-UxcxYS1MaTusSgyifQDqdeepyD
SBIA LinkedIn - https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
SBIA Training Resources - https://www.fda.gov/cdersbialearn
Twitter - https://twitter.com/FDA_Drug_Info
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

OTC Monograph Reform: Deemed Final Orders

Next Post

FDA Approves Pfizer Booster Shots for Children Aged 12 to 15

Related Posts
Total
0
Share